User profiles for Y. Nashed-Samuel

Yasser Nashed

Amgen
Verified email at amgen.com
Cited by 1937

[HTML][HTML] Classification and characterization of therapeutic antibody aggregates

MK Joubert, Q Luo, Y Nashed-Samuel… - Journal of Biological …, 2011 - ASBMB
A host of diverse stress techniques was applied to a monoclonal antibody (IgG 2 ) to yield
protein particles with varying attributes and morphologies. Aggregated solutions were …

Identification of a leachable compound detrimental to cell growth in single-use bioprocess containers

…, AL Marghitoiu, L Perez, Y Nashed-Samuel… - PDA Journal of …, 2013 - journal.pda.org
Out of the plethora of chemical species extractable at low levels from the materials of construction
of single-use bioprocess containers, we have identified one particularly conspicuous …

Tungsten‐induced protein aggregation: Solution behavior

Y Jiang, Y NashedSamuel, C Li, W Liu… - Journal of …, 2009 - Wiley Online Library
Tungsten has been associated with protein aggregation in prefilled syringes (PFSs). This study
probed the relationship between PFSs, tungsten, visible particles, and protein aggregates…

Root cause analysis of tungsten-induced protein aggregation in pre-filled syringes

…, Y Nashed-Samuel, ZQ Wen, Y Jiang… - PDA Journal of …, 2010 - journal.pda.org
Particles isolated from a pre-filled syringe containing a protein-based solution were identified
as aggregated protein and tungsten. The origin of the tungsten was traced to the tungsten …

A cytotoxic leachable compound from single‐use bioprocess equipment that causes poor cell growth performance

…, L Perez, G Rogers, Y NashedSamuel… - Biotechnology …, 2014 - Wiley Online Library
A current trend in the production of biopharmaceuticals is the replacement of fixed stainless
steel fluid‐handling units with disposable plastic bags. Such single‐use systems (SUS) offer …

Creating a holistic extractables and leachables (E&L) program for biotechnology products

K Li, G Rogers, Y Nashed-Samuel, H Lee… - PDA Journal of …, 2015 - journal.pda.org
The risk mitigation of extractables and leachables presents significant challenges to
regulators and drug manufacturers with respect to the development, as well as the lifecycle …

Analysis of silicone oil in prefilled syringes and biopharmaceutical drug products using high-performance liquid chromatography

…, M Ronk, K Fujimori, H Lee, Y Nashed-Samuel - AAPS PharmSciTech, 2021 - Springer
As the packaging of choice for many therapeutic proteins, prefilled syringes have been widely
used in biopharmaceutical industry as primary containers, where silicone oil is applied to …

A holistic approach of extractables and leachables assessment of rubber stoppered glass vial systems for biotechnology products

…, Y Luo, K Li, H Lee, Y Nashed-Samuel - Journal of …, 2021 - Elsevier
… The condition of 70C for 4 days was calculated based on the Arrhenius equation, to
approximate 1 y of drug product storage at 5C, which indicates a 10C increase in temperature …

Interactions between therapeutic proteins and acrylic acid leachable

D Liu, Y Nashed-Samuel, PV Bondarenko… - PDA Journal of …, 2012 - journal.pda.org
Leachables are chemical compounds that migrate from manufacturing equipment, primary
containers and closure systems, and packaging components into biopharmaceutical and …

Extractables analysis of single-use flexible plastic biocontainers

…, A Lower, G Rogers, Y Nashed-Samuel - PDA Journal of …, 2015 - journal.pda.org
Studies of the extractable profiles of bioprocessing components have become an integral
part of drug development efforts to minimize possible compromise in process performance, …